These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22495990)

  • 41. Reappraisal of eligibility criteria in cancer clinical trials.
    Penel N; Lebellec L; Vanseymortier M
    Curr Opin Oncol; 2018 Sep; 30(5):352-357. PubMed ID: 30020120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Out of the box.
    Gelenberg AJ
    Arch Gen Psychiatry; 2002 Mar; 59(3):281. PubMed ID: 11879167
    [No Abstract]   [Full Text] [Related]  

  • 43. IDENTIFICATION OF QUESTIONABLE EXCLUSION CRITERIA IN MENTAL DISORDER CLINICAL TRIALS USING A MEDICAL ENCYCLOPEDIA.
    Ma H; Weng C
    Pac Symp Biocomput; 2016; 21():219-30. PubMed ID: 26776188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exclusion criteria and generalizability in bipolar disorder treatment trials.
    Wong JJ; Jones N; Timko C; Humphreys K
    Contemp Clin Trials Commun; 2018 Mar; 9():130-134. PubMed ID: 29696235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of group-to-individual generalizability is a threat to human subjects research.
    Fisher AJ; Medaglia JD; Jeronimus BF
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6106-E6115. PubMed ID: 29915059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simulation-based Evaluation of the Generalizability Index for Study Traits.
    He Z; Chandar P; Ryan P; Weng C
    AMIA Annu Symp Proc; 2015; 2015():594-603. PubMed ID: 26958194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatic volunteers in multicenter drug trials.
    Covi L; Lipman RS; McNair DM; Czerlinsky T
    Prog Neuropsychopharmacol; 1979; 3(5-6):521-33. PubMed ID: 401003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of Temporal Constraints in Qualitative Eligibility Criteria of Cancer Clinical Studies.
    He Z; Chen Z; Bian J
    Proceedings (IEEE Int Conf Bioinformatics Biomed); 2016 Dec; 2016():717-722. PubMed ID: 29263940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trial participants need to be more representative of patients.
    Roehr B
    BMJ; 2008 Apr; 336(7647):737. PubMed ID: 18390507
    [No Abstract]   [Full Text] [Related]  

  • 50. Limits to Generalizability of the TINGLE Trial.
    Kuhnen AH
    Dis Colon Rectum; 2022 Oct; 65(10):e958. PubMed ID: 34657079
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychological interventions for generalized anxiety disorder: Effects and predictors in a naturalistic outpatient setting.
    Krzikalla C; Morina N; Andor T; Nohr L; Buhlmann U
    PLoS One; 2023; 18(3):e0282902. PubMed ID: 36897860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors Influencing Community Participation in Internet Interventions Compared With Research Trials: Observational Study in a Nationally Representative Adult Cohort.
    Batterham P; Gulliver A; Sunderland M; Farrer L; Kay-Lambkin F; Trias A; Calear A
    J Med Internet Res; 2023 Feb; 25():e41663. PubMed ID: 36729613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes associated with antidepressant treatment according to the number of prescriptions and treatment changes: 5-year follow-up of a nation-wide cohort study.
    Ouazana-Vedrines C; Lesuffleur T; Cuerq A; Fagot-Campagna A; Rachas A; Gastaldi-Ménager C; Hoertel N; Limosin F; Lemogne C; Tuppin P
    Front Psychiatry; 2022; 13():923916. PubMed ID: 36159949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine.
    Stein DJ
    Adv Ther; 2021 Sep; 38(Suppl 2):52-60. PubMed ID: 34417992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perceived helpfulness of treatment for generalized anxiety disorder: a World Mental Health Surveys report.
    Stein DJ; Kazdin AE; Ruscio AM; Chiu WT; Sampson NA; Ziobrowski HN; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Altwaijri Y; Bruffaerts R; Bunting B; de Girolamo G; de Jonge P; Degenhardt L; Gureje O; Haro JM; Harris MG; Karam A; Karam EG; Kovess-Masfety V; Lee S; Medina-Mora ME; Moskalewicz J; Navarro-Mateu F; Nishi D; Posada-Villa J; Scott KM; Viana MC; Vigo DV; Xavier M; Zarkov Z; Kessler RC;
    BMC Psychiatry; 2021 Aug; 21(1):392. PubMed ID: 34372811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicians' Perceptions of Rapid Scale-up of Telehealth Services in Outpatient Mental Health Treatment.
    Sugarman DE; Horvitz LE; Greenfield SF; Busch AB
    Telemed J E Health; 2021 Dec; 27(12):1399-1408. PubMed ID: 33600272
    [No Abstract]   [Full Text] [Related]  

  • 57. Target validity: Bringing treatment of external validity in line with internal validity.
    Lesko CR; Ackerman B; Webster-Clark M; Edwards JK
    Curr Epidemiol Rep; 2020 Sep; 7(3):117-124. PubMed ID: 33585162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies.
    Stein DJ; Khoo JP; Picarel-Blanchot F; Olivier V; Van Ameringen M
    Adv Ther; 2021 Mar; 38(3):1567-1583. PubMed ID: 33537871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Who Is Seeking Help for Sleep? A Clinical Profile of Patients in a Sleep Psychology Clinic.
    Vallières A; Pappathomas A; Araújo T; Crawford MR; de Billy Garnier S
    Int J Behav Med; 2021 Apr; 28(2):207-213. PubMed ID: 32405918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications.
    Venegas A; Meredith LR; Cooper ZD; Towns B; Ray LA
    Alcohol Alcohol; 2020 Jun; 55(4):416-423. PubMed ID: 32328657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.